保留肠道,不损靶区:宫颈癌在线锥形束自适应放疗(OnC-ART)的最佳外扩边界评估
该回顾性队列纳入21例接受根治性放化疗的宫颈癌患者,在9例非自适应放疗患者中于治疗前及治疗结束时的锥形束CT上勾画子宫颈以计算位移并确定CTV至PTV外扩边界,并在12例接受OnC-ART的患者中验证。结果显示均匀5 mm外扩可覆盖治疗结束时CTV的98.85%±1.23%,验证队列覆盖98.39%±3.0%;锥形束CT间隔>30分钟和膀胱体积变化与CTV覆盖显著相关。作者推荐医生从5 mm边界开始,并在每日自适应期间通过影像引导评估覆盖是否充分。
要点
- 均匀5 mm外扩在非自适应队列覆盖治疗结束时CTV的98.85%±1.23%,在OnC-ART验证队列覆盖98.39%±3.0%。
- 锥形束CT间隔>30分钟和膀胱体积变化与CTV覆盖显著相关。
- 作者推荐医生从5 mm边界开始,并在每日自适应期间通过影像引导评估覆盖是否充分。
核心结论
- 基于本分析,5 mm的CTV至PTV外扩边界足以覆盖98%的CTV。
- 显著缩小的边界可能减少宫颈癌患者放疗相关毒性并改善患者报告的毒性结局。
- 作者推荐医生从5 mm边界开始,并在每日自适应期间通过影像引导评估覆盖是否充分。
研究设计与样本
- 回顾性队列纳入21例接受根治性放化疗的宫颈癌患者。
- 9例接受非自适应放疗的患者在治疗前锥形束CT和治疗结束时锥形束CT上勾画子宫颈,计算前后、侧方、上下方向及所有方向平均位移。
- 在12例接受OnC-ART的患者验证队列中确定并验证CTV至PTV外扩边界。
主要发现
- 前后、侧方、上下方向平均位移及标准差分别为0.32±1.55 cm、0.12±2.31 cm、1.67±3.41 cm。
- 治疗前CTV均匀外扩5 mm覆盖治疗结束时CTV的98.85%±1.23%。
- 该5 mm外扩应用于OnC-ART验证队列,覆盖治疗结束时CTV的98.39%±3.0%。
- 锥形束CT间隔>30分钟和膀胱体积变化与CTV覆盖显著相关。
关键数值与推荐
- CTV至PTV外扩边界为5 mm。
- 5 mm外扩在非自适应队列覆盖治疗结束时CTV的98.85%±1.23%,在OnC-ART验证队列覆盖98.39%±3.0%。
临床怎么用
- 作者推荐医生从5 mm边界开始,并在每日自适应期间通过影像引导评估覆盖是否充分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The standard treatment for locally advanced cervical cancer involves pelvic chemoradiation. Intensity modulated radiation therapy planning requires expansion of the cervix and uterus clinical target volume (CTV) by 1.5 to 2 cm to account for motion. With online cone beam adaptive radiation therapy (OnC-ART), interfractional movement is accounted for, which can potentially lead to smaller CTV to planned target volume (PTV) margins. In this study, we attempted to determine the optimal CTV-to-PTV margin for adequate coverage with OnC-ART and factors that can affect CTV coverage. METHODS AND MATERIALS: A retrospective cohort of 21 patients with cervical cancer treated with definitive chemoradiation was included. Nine patients treated with nonadaptive radiation had the uterocervix contoured on pretreatment cone beam computed tomography (CBCT) and end-treatment CBCTs. Anterior-posterior, lateral, and superior-inferior shifts and the average shift in all directions were calculated. A CTV-to-PTV expansion was determined and verified on a validation cohort of 12 patients treated with OnC-ART. RESULTS: The average anterior-posterior, lateral, and superior-inferior shifts with standard deviation were 0.32 ± 1.55 cm, 0.12 ± 2.31 cm, and 1.67 ± 3.41 cm, respectively. A uniform 5-mm expansion around the pretreatment CTV covered 98.85% ± 1.23% of the end-treatment CTV. This 5-mm expansion was applied to our validation cohort treated with OnC-ART, and 98.39% ± 3.0% of the end-treatment CTV was covered. Time between CBCTs >30 minutes and change in bladder volume were significantly correlated to CTV coverage. CONCLUSIONS: Based on our analysis, a CTV-to-PTV margin of 5 mm is adequate to encompass 98% of the CTV. A significantly reduced margin could potentially decrease the toxicities associated with radiation for patients with cervical cancer and lead to improved patient reported toxicity outcomes. We recommend physicians begin with a 5-mm margin and assess adequate coverage with image guidance during daily adaptation.
引用
- Yen A, Choi B, Inam E, et al. Spare the Bowel, Don't Spoil the Target: Optimal Margin Assessment for Online Cone Beam Adaptive Radiation Therapy (OnC-ART) of the Cervix. Pract Radiat Oncol. 2022. PMID: 36356834. doi:10.1016/j.prro.2022.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。